Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults

Drugs and Aging

Volumn 23, Issue 4, 2006, Pages 345-356

  Vik, Shelly A ^a   Hogan, David B ^a,b   Patten, Scott B ^a,b,c   Johnson, Jeffrey A ^c,d   Romonko Slack, Lori ^e   Maxwell, Colleen J ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c INSTITUTE OF HEALTH ECONOMICS   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e CALGARY HEALTH REGION   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; EMERGENCY WARD; FEMALE; FOLLOW UP; GERIATRIC CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SELF REPORT; SMOKING; URBAN AREA; VISUAL DISORDER;

AGED; AGED, 80 AND OVER; CANADA; DRUG UTILIZATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MORTALITY; PREVALENCE; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 33744793211     PISSN: 1170229X     EISSN: 1170229X     Source Type: Journal    
DOI: 10.2165/00002512-200623040-00007     Document Type: Article

References (55)

1. Bergob M. Drug use among Canadian seniors. Statistics Canada [online]. Available from URL: http://www.statcan.ca/english/ads/11-008-XIE/drugs.htm [Accessed 2005 Jul 6]
2. Stagnitti MN. Statistical Brief #21. Trends in outpatient prescription drug utilization and expenditures: 1997-2000. Medical Expenditure Panel Survey [online]. Available from URL: http://www.meps.ahrq.gov/papers/st21/stat21.pdf [Accessed 2004 Nov 1]
3. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38 (2): 303-12
4. Horwitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336 (8714): 542-5
5. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, et al. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 1991; 32 (1): 35-42
6. Kessenich CR, Guyatt GH, Rosen CJ. Health-related quality of life and participation in osteoporosis clinical trials. Calcif Tissue Int 1998; 62 (3): 189-92
7. Sociodemographic and clinical predictors of participation in two randomized trials: findings from the Collaborative Ocular Melanoma Study COMS report no. 7. Control Clin Trials 2001; 22 (5): 526-37
8. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150 (4): 841-5
9. Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703-7
10. Grymonpre RE, Mitenko PA, Sitar DS, et al. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988; 36 (12): 1092-8
11. McKenney JM, Harrison WL. Drug-related hospital admissions. Am J Hosp Pharm 1976; 33 (8): 792-5
12. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 2005. Epub 2005 Dec 1
13. Maronde RF, Chan LS, Larsen FJ, et al. Underutilization of antihypertensive drugs and associated hospitalization. Med Care 1989; 27 (12): 1159-66
14. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43 (6): 521-30
15. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood) 2003; 22 (4): 220-9
16. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000; 20 (8): 941-9
17. Matuszewski MS, Velayudhan MA, Flint N, et al. Noncompliance with drug therapy for chronic obstructive pulmonary disease: a risk factor for hospitalization? Value Health 1999; 2 (6): 446-51
18. Garcia-Aymerich J, Monso E, Marrades RM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation: EFRAM study. Am J Respir Crit Care Med 2001; 164 (6): 1002-7
19. Aparasu RR, Sitzman SJ. Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm 1999; 56 (5): 433-9
20. Innovations in rural and community health: Federal budget information. Ottawa (ON): Health Canada, 1999
21. Government of Alberta. Municipal Government Act, Statutes of Alberta: consolidated to June 9, 1999. Edmonton (AB): Queen's Printer for Alberta, 1999: M-26, Part 4
22. Ramachandran H, Shastri GS. Movement for medical treatment: a study in contact patterns of rural population. Soc Sci Med 1983; 17 (3): 177-87
23. Lucas CA, Rosenthal TC. Access to health care in rural western New York State. N Y State J Med 1992; 92: 465-8
24. Hawe P, Higgins G. Can medication education improve the drug compliance of the elderly? Evaluation of an in hospital program. Patient Educ Couns 1990; 16 (2): 151-60
25. Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996; 101 (3): 270-6
26. Vik SA, Maxwell CJ, Hogan DB, et al. Determinants and health related outcomes associated with nonadherence to prescribed drug regimens: a comparison of rural and urban home care clients. Institute of Health Economics Working Paper 03-02, Edmonton, AB [online]. Available from URL: http://www.ihe.ca/ publications/papers/index.cfm?.year =2003 [Accessed 2003 Jan]
27. Morris JN, Fries BE, Steel K, et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc 1997; 45 (8): 1017-24
28. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24 (1): 67-74
29. Vik SA, Maxwell CJ, Hogan DB, et al. Assessing medication adherence among older persons in community settings. Can J Clin Pharmacol 2005; 12 (1): e152-64
30. Hirdes JP, Frijters DH, Teare GF. The MDS-CHESS scale: a new measure to predict mortality in institutionalized older people. J Am Geriatr Soc 2003; 51 (1): 96-100
31. Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 1999; 54 (11): M546-53
32. Hartmaier SL, Sloane PD, Guess HA, et al. Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J Gerontol A Biol Sci Med Sci 1995; 50 (2): M128-33
33. Burrows AB, Morris JN, Simon SE, et al. Development of a Minimum Data Set-based Depression Rating Scale for use in nursing homes. Age Ageing 2000; 29 (2): 165-72
34. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163 (22): 2716-24
35. Conn VS, Taylor SG, Kelley S. Medication regimen complexity and adherence among older adults. Image J Nurs Sch 1991; 23 (4): 231-5
36. Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly: a controlled trial of physician feedback. J Am Geriatr Soc 1990; 38: 31-6
37. Kleinbaum DG. Evaluating the proportional hazards assumption. In: Dietz K, Gail M, Krickeberg K, et al., editors. Survival analysis: a self-learning text. New York: Springer Verlag, 1996
38. Stata Statistical Software. Release 8.0 ed. College Station (TX): Stata Corporation, 2003
39. Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure. J Clin Epidemiol 1997; 21: 294-300
40. Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32 (7-8): 749-54
41. Flaherty JH, Perry III HM, Lynchard GS, et al. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 2000; 55 (10): M554-9
42. Weintraub M. Intelligent noncompliance with special emphasis in the elderly. Contemp Pharm Pract 1981; 4 (1): 8-11
43. Inui TS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension: is self-report the best available measure? Med Care 1981; 19 (10): 1061-4
44. Cargill JM. Medication compliance in elderly people: influencing variables and interventions. J Adv Nurs 1992; 17 (4): 422-6
45. Raffoul PR, Cooper JK, Love DW. Drug misuse in older people. Gerontologist 1981; 21 (2): 146-50
46. Monane M, Bohn RL, Gurwitz JH, et al. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154 (4): 433-7
47. Monane M, Bohn RL, Gurwitz JH, et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10 (7 Pt 1): 697-704
48. Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology 1995; 14 (1): 88-90
49. Coons SJ, Sheahan SL, Martin SS, et al. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994; 16 (1): 110-7
50. Spiers MV, Kutzik DM. Self-reported memory of medication use by the elderly. Am J Health Syst Pharm 1995; 52: 985-90
51. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289 (9): 1107-16
52. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45 (10): 1045-51
53. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994; 150 (11): 1801-9
54. Higgins N, Regan C. A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age Ageing 2004; 33 (3): 224-9
55. Metlay JP, Cohen A, Polsky D, et al. Medication safety in older adults: home-based practice patterns. J Am Geriatr Soc 2005; 53 (6): 976-82